
As artificial intelligence (AI) use continues to grow in nearly every industry, it is important to establish guardrails to make sure the technology is used ethically and responsibly. This is especially true in the field of medicine, where errors can be a matter of life and death and patient information must be protected.
A group of stroke physicians, researchers and industry representatives discussed the current use and future of AI in stroke clinical trial design at the Stroke Treatment Academic Industry Roundtable meeting March 28. Led by the University of Cincinnati’s Joseph Broderick, MD, the researchers published an article in the journal Stroke Sept. 30 summarizing the group’s discussion.
#WeAreMayoClinic